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Abstract
This paper studies the relationship between the diffusion of innovative procedures for the treat-
ment of heart attack and the distributions of the cost and length of hospital stays. Using a sample
of 5,681 stays observed in French publics hospitals, we use microsimulation techniques in order to
highlight various effects on the shifts in the overall distributions of the costs and length of stays :
(i) the effect of the adoption of new techniques by hospitals (between hospital diffusion) ; (ii) the
effect of the diffusion of technological progress within hospitals ; (iii) the effect of the evolutions of
patients characteristics (age x gender, comorbidities). This decomposition approach is used in the
litterature relative to the relationship between education and income distribution where observed
distributions are compared to counterfactual distributions built by replacing some estimated para-
meters with their counterparts estimated from another country or period. Our results show that
between 1994 and 1997 hospitals faced two main causes of rises in costs : on the one hand, diffusion
of technological progress, with increasing use of costly innovative procedures such as angioplasty ;
on the other hand, patients’ epidemiological state worsened, since they became older and had more
secondary diagnoses. These two factors induced sizeable shocks in cost distributions. During the
same period, French public hospitals were financed by a global budget, and their budgets increased
very slowly. However, international comparisons show that diffusion of technological progress for
AMI treatment is similar in France and in comparable countries. How did French hospitals deal
with their financial constraints ? Our results show that they sharply reduced the length of stays for
patients at the bottom of the distribution. This reduction in the length of stays appears to have
been a condition for the diffusion of angioplasty. Obviously, such a condition cannot be sustained
in the long run without jeopardizing quality of care.
2
1 Introduction
This paper studies the relationship between the diffusion of innovative procedures and the
evolutions of the cost and length of hospital stays. In contrast with macroeconomic evaluations,
where the influence of technological progress is often reduced to a trend, microeconomic empirical
evidence, from a sample of individual hospital stays, is used here. This allows us to use a direct
information about the diffusion of technological progress and to evaluate the effects of technological
progress on costs at different places of the costs distribution.
In the case of health care, direct information on technological progress diffusion can be gathered
by observing changes in the use of innovative treatments and substitution between treatments.
We focus on patients hospitalized with acute myocardial infarction. For these patients, the use of
innovative procedures (such as angioplasty) is growing rapidly in all developed countries (TECH,
(2001)). These procedures are less costly than more traditional ones (such as bypass surgery) and
less invasive, i.e. more respectful of patients’ quality of life. In some cases, innovative procedures
can replace more traditional procedures. However, the use of innovative procedures is spreading in
any case, independently of this type of substitution.
Performing such procedures requires investment in specific training and high-tech equipment.
The process of diffusion of technological progress is thus composed of two steps : (i) adoption of
new techniques by hospitals, (ii) an increase in the use of innovative procedures by hospitals which
are able to perform them.
Diffusion of innovative procedures can have several effects on treatment costs. The implementa-
tion of the procedure can induce a direct increase in cost for each stay, plus an indirect increase due
to the potential influence of the procedure on the stay duration. Diffusion of innovative procedures
leads to a more frequent use and thus amplifies the increase in the average cost of heart attack
treatment. However, an innovative procedure such as angioplasty can reduce treatment cost when
it replaces a traditional procedure such as bypass surgery.
Our data covers public and private not-for-profit hospitals in France. We have a database with
three dimensions (stays-hospitals-years) at our disposal relative to 11,573 stays for acute myocardial
infarction observed over the period 1994 to 1997. Concentrating our analysis on cross-sections
relative to years 1994 and 1997, we finally used a sample of 5,681 stays.
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The study entails three stages.
In the first stage, we use a descriptive approach to characterize the pace and patterns of diffusion
of innovative procedures for treating heart attacks, as well as the main features of AMI patients.
In the second stage, we estimate a four equations model explaining, for one AMI-patient in a
given year, the cost and the length of stay, the probability of being assigned to an innovative hospital
(which has adopted the new techniques), and - conditional on the assignment to an innovative
hospital- the probability of use of an innovative procedure. This model is estimated for the first and
last years of our observation period, i.e. 1994 and 1997. The estimations allow us to evaluate the
additional cost attributable to the use of an innovative procedure.
The purpose of the third stage is to evaluate the influence of diffusion of technological progress on
the distribution of treatment costs and length of stays. The principle of our analysis is the following :
we use the probability of implementation of an innovative procedure, estimated on the basis of the
1997 data, to simulate the cost and length of stays for patients observed in 1994. Comparison of
the result with actually observed or predicted costs for 1994 will allow us to assess the impact of
diffusion of technological progress on treatment costs. A similar computation can be carried out
using patients observed in 1997 as a reference. More precisely, we use microsimulation techniques in
order to highlight various effects on the shifts in the overall distributions of the costs and length of
stays : (i) the effect of the adoption of new techniques by hospitals (between hospital diffusion) ; (ii)
the effect of the diffusion of technological progress within hospitals ; (iii) the effect of the changes
in patients characteristics (age x gender, comorbidities). This decomposition approach is used in
the litterature relative to the relationship between education, development and income distribution
(Juhn, Murphy and Pierce (1993), DiNardo, Fortin and Lemieux (1996), Bourguignon, Ferreira and
Leite (2002)), where observed distributions are compared to counterfactual distributions built by
replacing some estimated parameters with their counterparts estimated from another country or
period .
2 Pace and patterns of innovative procedures diffusion
We have at our disposal a sample of 11,538 stays for acute myocardial infarction (AMI) observed
in 44 French hospitals operating in the public sector over the period 1994-1997. In France, public
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hospitals1 account for most of the total admissions (2/3 of admissions for AMI). Our sample has
been extracted from the PMSI2 cost database. Classification of stays by Diagnosis Related Group
(DRG) is performed on the basis of diagnoses and procedures implemented during the stay. In order
to obtain a high degree of patient homogeneity in terms of pathologies, we selected patients aged
at least 40 years with acute myocardial infraction (AMI) as the main diagnosis and grouped in
the DRGs 178 (complicated AMI) and 179 (uncomplicated AMI). For the purpose of our empirical
exercise, we restricted the sample to two cross-sections : 2,269 and 3,412 stays observed in 1994 and
1997.
2.1 The AMI treatment
Together with drug therapy (aspirin, beta blockers, etc.), AMI patients can receive various
treatments such as thrombolytic drugs, cardiac catheterization (hereafter denoted as CATH) and
percutaneous transluminal coronary angioplasty (PTCA). Catheterization is a specialized procedure
used to view the blood flow to the heart in order to improve the diagnosis. Angioplasty (PTCA) ap-
peared more recently than bypass surgery. It is an alternative, less invasive procedure for improving
blood flow in a blocked artery. This procedure is costly : its implementation induces an additional
cost for one stay which ranges between 30 % and 60 %. General statistics performed on the total
sample of AMI patients show that most of angioplasty are grouped in DRGs 179 and 178. Bypass
surgery is implemented for a very small proportion, less than 3 % of AMI patients.
2.2 Innovation incentives within the French regulation
In France, public hospitals represent approximately 75 percent of the acute care beds. The
financial incentives are quite different in the private and public sectors (Jacobzone and alii (2002)
and Milcent (2003)). Public hospitals are financed by a global budget and their doctors are salaried.
A deterrent to public sector use of innovative procedures is the financing of supplies from a global
budget, which makes it difficult for them to purchase expensive devices. The global budget system
1 In France and in the present study, the term ”public hospitals” stands for hospitals belonging to the public sector
as well as most of the private-not-for-profit hospitals.
2PMSI stands for the Programme de médicalisation des systèmes d’informations, which collects information about
hospital activity. Information about the cost of the stays is available only from a hospitals sub-sample called ”Base
nationale de coûts”.
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does not take costly procedures such as catheterization or angioplasty into account and therefore
penalises the public innovative hospitals which use them. On the opposite, most private hospitals
are financed on the basis of a fee-for-service system. Supplies such as stents are reimbursed ex-post
in addition to the fee-for-service payment and physicians receive additional fees for performing these
procedures.
However, these different incentives do not lead to very contrasted physician behaviors. Milcent
(2003) observes that large or middle-sized hospitals of all types (private, private-not-for-profit and
public) have comparable significant rates of use of innovative procedures.
This can be interpreted by the existence of many indirect financial or non financial incentives
for physicians working in the public sector. In teaching hospitals, physicians are involved in the
international competition for research. Their career depends partly on their success in scientific
publications. In addition, the allocation of the budget relies also on the hospital’s reputation.
2.3 Basic features of the data
Our sample concerns stays observed in French public hospitals. These hospitals are regulated
by a global budget system, with an increase in budgets close to zero in real terms during the period
1994-1997 that we study.
Table 1 reports statistics computed for the first (1994) and last (1997) year of our observation
period. Indeed, our empirical study focuses on changes between these two years.
Most of the patients are men. The average age of the patients is the same in 1994 and 1997 :
67 years. A characteristic feature of heart disease is illustrated by figure 3 : young AMI patients
are male ; the majority of AMI patients aged 75 and over are female. The proportions of male and
female in age categories are quite similar in the years 1994 and 1997. Patients are slightly aging
between these two years.
The epidemiological state of AMI patients is worsening : their number of secondary diagnosis is
increasing rapidly (table 1). The proportion of patients with at least one non coronary secondary
diagnosis is increasing, as well as the proportion of patients with at least one coronary secondary
diagnosis. Figures 1 and 2 show the increase in the frequency of some particular secondary diagnoses :
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arrhythmia, hypertension, heart failure, cerebrovascular disease and peripheral arterial disease3.
Our indicator of the use of innovative procedures is the proportion of patients treated by an
angioplasty. The table shows that the overall rate of use of this innovative procedure is growing
rapidly in France : it went from 4.8 % of stays in 1994 to 15.6 % in 1997. More general statistics,
computed on a larger sample of AMI patients and not reported here, show that angioplasty can
replace more traditional procedures such as bypass surgery. However, this substitution effect explains
only a small part of the increase in treatments by angioplasty.
Performing innovative procedures requires investment in specific training and high-tech equip-
ment. The process of diffusion of technological progress is thus composed of two steps : first, the
adoption of new techniques by hospitals ; second, the increase in the use of innovative procedures
by hospitals which are able to perform them. We call the first step between hospitals diffusion.
The second step is linked to a process of learning by doing (Ho (2002)) : we call it within hospitals
diffusion. Between and within diffusion4 are illustrated by figure 4. The proportion of hospitals able
to perform innovative procedures is increasing rapidly. The proportion of angioplasty implemented
within innovative hospitals is growing even more rapidly. These patterns are comparable to the pace
of technological progress diffusion observed in comparable developped countries (TECH, 2001).
Table 1 also gives some information about the average length (LOS) and cost (C) of the stay.
The average length of stay does not seem to be influenced by the performance of an angioplasty
and decreases sharply between 1994 and 1997. On the contrary, a stay is much more costly when
an innovative procedure has been implemented. The average cost per stay increased slightly, from
4,361.7 Euros in 1994 to 4,611.2 Euros in 1997, i.e. an increase in nominal terms of 5.7 % between
1994 and 1997.
This illustrates the strength of the global budget constraint during this period, with an increase
of the average budget close to zero in real terms. During the same time, we have observed (figure 4)
that the pace of technological progress diffusion is sizeable. How did hospitals manage to increase
the use of innovative procedure in the context of such a financial constraint ? What is the nature
3One should be cautious about the interpretation of such an increase in the secondary diagnoses. It is likely to be
the sign of a real worsening of patients’ state. However, it can also be influenced by changes in physicians’ behavior
towards a more systematic registration of diagnoses. These changes in registration behavior are encouraged by the
perspective of hypothetical reform in hospital payment system.
4The hospitals able to perform innovative procedures are called ”innovative hospitals” and denoted IH.
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of the link between the decrease in the length of stay and the technological progress diffusion ?
3 The empirical approach
Our purpose is to implement microsimulation techniques in order to examine the influence of
various effects on the shifts in the distributions of the costs and length of stays. Our empirical
approach entails two steps : firstly, the specification and estimation of a model explaining the
length and costs of stays, as well as the diffusion of innovative procedures ; secondly, the use of the
estimates to simulate counterfactual distributions which make it possible to evaluate the impacts of
technological progress diffusion and changes in patients’ characteristics. In this section, we present
the econometric specification (3.1) and the principles of our microsimulations (3.2).
3.1 Econometric specification
For the patient i and the year τ , we consider the following model :
IHiτ = IIH∗iτ>0 with IH
∗
iτ = x
0
iτBτ + νiτ (1)
prociτ = IPr oc∗iτ>0 with proc
∗
iτ = x
0
iτDτ + µiτ if IH
∗
iτ > 0 (2)
Log(LOSiτ ) = x0iτdτ + IHiτaτ + prociτpτ + cτ + ξiτ (3)
Log(Ciτ ) = x
0
iτδτ + LOSiτθτ + IHiτατ + prociτπτ + γτ + uiτ (4)
This model has a recursive structure5 and entails two assignment equations and two equations
explaining respectively the length and the cost of the stay.
The first assignment equation (1) explains, for a given patient’s demographical and epidemiolo-
gical characteristics x0, the assignment to an innovative hospital. IH is a dichotomic variable taking
the value 1 if the patient is assigned to a hospital able to perform angioplasty. The second assign-
ment equation (2) explains, conditional on assignment to an innovative hospital, the probability of
being treated through the use of an angioplasty. proc is a dichotomic variable taking the value 1 if
the patient is treated by an angioplasty. Equation (3) explains the logarithm of the length of the
5One has : (1)⇒(2)⇒(3)⇒(4) .
8
stay by the patient’s characteristics x0, the potential assignment to an innovative hospital and the
potential treatment by an angioplasty. Equation (4) explains the logarithm of the cost of the stay
by the same explanatory variables and the length of the stay.
In order to analyse the changes in the distributions of the lengths of stays and costs between
1994 and 1997, we estimate this four-equation model on the two cross-sections corresponding to the
years 1994 and 1997. Despite we adopt a parametric approach, our estimates are rather flexible.
Indeed, all the coefficients are allowed to change between 1994 and 1997.
3.2 Analysing changes in the distributions of treatment costs and length
of stays
We now denote by Λτ the overall distribution of Log(LOS) at time τ and by Γτ the overall
distribution of Log(C) at time τ . These distributions can be expressed as vector functions of ob-
servable and unobservable patient’s characteristics and of the parameters at date τ . In our study,
τ is equal to 1994 or 1997, denoted by 0 or 1 for the sake of simplicity.
Λτ = Λ {x0iτ , εiτ ; (Bτ ,Dτ , dτ , aτ , pτ , cτ )} , where εiτ = (νiτ , µiτ , ξiτ ) .
Γτ = Γ {x0iτ , iτ ; (Bτ ,Dτ , dτ , aτ , pτ , cτ , δτ , θτ , ατ , πτ , γτ )} , where iτ = (νiτ , µiτ , ξiτ , uiτ ) .
These distributions are represented in graphs6 1 and 2. Their changes between 0 and 1, Λ1−Λ0
and Γ1 − Γ0, are displayed in graphs 1a and 2a. They can be explained by several effects :
i) The effect of the growing adoption of new techniques by hospitals. This between hospital
diffusion is linked to a change from B0 to B1 in the coefficients of (1). With given demographical
and epidemiological characteristics, a patient has a higher probability of being assigned to an
innovative hospital in year 1 than in year 0.
ii) The effects of the within hospital diffusion should result in a change from D0 to D1 in the
coefficients of (2).
iii) The effect of changes in patients’ demographical (age, gender) and epidemiological (secondary
diagnoses) characteristics. This population effect is related to changes in the observable (x0iτ ) and
unobservable (εiτ , iτ ) patient characteristics.
6The distributions reported in this paper are kernel density estimates displayed by the software Stata. We used
the Epanechnikov as kernel function and the default value chosen by the software for the bandwidth. On the other
hand, the differences in densities displayed in this paper have been smoothed using a program provided by Stata.
9
The effects of the between and within hospital diffusion of innovative procedures on the costs
and lengths of stays is more or less important, depending on their direct and indirect influences,
which are captured through the coefficients aτ , pτ , ατ , πτ and θτ in (3) and (4). Shifts in the overall
distributions depend on the three effects mentionned above and on the changes in all these other
coefficients. In particular, changes from π0 to π1 can be linked to the changes in supply prices.
Consider now the overall distributions Λ0 and Γ0 of the logarithms of the length of stays and
of costs at time 0 :
Λ0 = Λ {x0i0, εi0 ; (B0,D0, d0, a0, p0, c0)} (5)
Γ0 = Γ {x0i0, i0 ; (B0,D0, d0, a0, p0, c0, δ0, θ0, α0, π0, γ0)} (6)
The effects defined above can be evaluated as follows :
1) Between hospital diffusion :
dΛ
0.1(B) = Λ0.1(B) − Λ0 (7)
where Λ0 is defined by (5) and Λ0.1(B) by :
Λ0.1(B) = Λ {x0i0, εi0 ; (B1,D0, d0, a0, p0, c0)} (8)
2) Within and between hospital diffusion :
dΛ
0.1(B.D) = Λ0.1(B.D) − Λ0 (9)
where Λ0.1(B.D) is defined by : Λ0.1(B.D) = Λ {x0i0, εi0 ; (B1,D1, d0, a0, p0, c0)}
One can evaluate in the same way these 2 effects on the overall distribution of costs Γ :
dΓ
0.1(B) = Γ0.1(B) − Γ0 and dΓ0.1(B.D) = Γ0.1(B.D) − Γ0 where Γ0 is defined by (6).
3) Finally, the distributions of length of stays and costs are also influenced by the patients’
demographical and epidemiological characteristics. We want to decompose the population effect
into what is due to the observable characteristics and what can be attributable to unobserved
heterogeneity. As stated by Bourguignon et al. (2001), it is possible to simulate a change in the
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distribution of unobservable characteristics through a rank-preserving transformation. When this
distribution is assumed to be normal with zero mean, this transformation is equivalent to :
εi,0.1 = εi0
σ1
σ0
, (10)
where εi,0.1 is the rank-preserving transformation7 of the distribution of εi0 in the distribution
observed at time 1. More exactly, it is the simulation of the unobserved heterogeneity of patient i ,
observed in year 0, if he or she were ill in year 1.
To evaluate the effects of changes in patients’ unobserved heterogeneity, one can compute :
dΛ0.1(ε) = Λ0.1(ε) − Λ0 (11)
with Λ0.1(ε) defined by :
Λ0.1(ε) = Λ {x0i0, εi,0.1 ; (B0,D0, d0, a0, p0, c0)} (12)
To evaluate now the additional effect of changes in observable characteristics, we have to consider
other individuals observed in year 1 :
dΛ0.1(x.ε) = Λ0.1(x.ε) − Λ0 (13)
with Λ0.1(x.ε) defined by :
Λ0.1(x.ε) = Λ
©
x0j1, εj,1 ; (B0,D0, d0, a0, p0, c0)
ª
(14)
The same reasoning is applied to evaluate the effects on the cost distribution of changes in
patient observable characteristics and unobserved heterogeneity.
Let us briefly comment the principle of our computations. As concerns for instance the between
and within diffusion effects, we compare the observed distribution at date 0 with an hypothetical
7More generally, a rank-preserving transformation of the distribution of εi0 observed in 0 in the distribution εi1
observed in 1 is given by : εi,0.1 = F
−1
1 [F0( εi0)] . Indeed, this leads to : F1(εi,0.1) = F0( εi0).
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(counterfactual) distribution obtained by simulating on the patients observed at date 0 , the be-
haviors at date 1. These behaviors are characterized by the parameters B1 (i.e. assignment to an
innovative hospital) and D1 (decision to treat with an innovative procedure). Given age, gender
and secondary diagnoses, one has a higher probability of being treated by an angioplasty in year 1
than in 0. We try to evaluate the impact of this effect on the costs and length of stays distributions.
Given the number of parameters of the four-equation model, one could simulate a very high number
of combinations for the various possible effects. Considering them exhaustively seemed to us of low
interest. We thus preferred to focus on the effects detailed above and then try to answer to questions
of specific interest.
As stated by DiNardo et alii (1996) and Bourguignon et alii (2002), this approach can be seen as
an extension of the Blinder-Oaxaca methodology to decompose the effects of discrimination between
two groups of individuals into differences in mean income due to different mean characteristics of
individuals in the two groups (here, our patients’ characteristics) and differences in how these
characteristics are remunerated within each group (here, the changes in parameters : how the same
epidemiological characteristics can lead to a higher use of innovative procedures in year 1 than in
year 0). The main change in our approach is that the decomposition is made on the full distribution
rather than on means. Indeed, since the innovative procedures are not performed to treat every
AMI patient, this diffusion of technological progress is likely not to affect the cost in the same way
at each place of the distribution.
This kind of decomposition can be dependent on the year taken as reference. Therefore, we
will compute, for the different effects, the evolutions dΛ
1.0(.)
and dΓ
1.0(.)
, in order to check for the
robustness of the results.
4 Results
In this section we first present the estimates of the four-equation model. Then, we use the results
of our estimates to compute decompositions on means of the overall changes observed between 1994
and 1997. Overall average changes are splitted into changes due to shifts in coefficients and changes
due to shifts in patient observable characteristics. This allows us to raise questions adressed in the
analysis of distributions performed in the last subsections, devoted to the impact of technological
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progress diffusion and of changes in patients’ characteristics.
4.1 Econometric estimates
The recursive model defined by (1) to (4) has been estimated equation by equation for the
years 1994 and 1997. A simple probit estimator has been used for equation (1), which explains
assignment to an innovative hospital. Equation (2) explains, conditional on this assignment, the
probability of being treated by an angioplasty. It has been estimated by a probit estimator with
selection8. For identification purpose, the selection equation entails additional regressors9 to the
explanatory variables of (2). Denoting ρ the correlation coefficient between the perturbations of the
probit equation and the selection equation of (2), the LR test leads us not to reject ρ = 0 for the
year 1994, but to reject ρ = 0 in 1997 (5%).
The estimates10 of (1) and (2) reveal that age has a significant negative influence on the proba-
bility of being assigned to an innovative hospital and on the probability of being treated with an
innovative procedure. We notice a sharp rise in the constants of the two equations between 1994 and
1997. In addition, the influence of having a non coronary secondary diagnosis on the assignment to
an innovative hospital increases significantly between these two years. These results illustrate the
rapid between and within hospital diffusion of technological progress.
Table 2 gives in more details the results of the estimations of (3) and (4). We performed Haus-
man’s tests to check for the exogeneity of the length of stay and of the dichotomous variables IH
and proc describing assignment to an innovative hospital and treatment by an angioplasty. The exo-
geneity of the length of stay being rejected in the cost equation for both years 1994 and 1997, this
variable has been instrumented11, as well as the variable proc, which appeared not to be exogenous
for the year 1997.
There is an average decrease in the length of the stay which is indicated by the change in the
constant : - 22.5 %, for the reference patient, a male aged 40-65, with no secondary diagnosis,
who is not in an innovative hospital and has not been treated by an angioplasty. The explanatory
8First considered by Van de Ven and Van Pragg (1981).
9Detailed indicators of secondary diagnosis, hospital size, cross effects of patient’s age and gender.
10Not reported here, available on request.
11For identification purposes, we had to consider instruments in addition to the explanatory variables of (3) in
the structural model : we thus included age squared, age raised to the third power and several detailed indicators of
secondary diagnosis (which are described in figures 1 and 2). These instruments are used for the estimation of (4)
and to perform the exogeneity test.
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variables of (3) and (4) relative to patients characteristics x0 include cross effects of patient’s gender
and age (four levels) and two dichotomic variables indicating whether the patient has at least one
non coronary secondary diagnosis and/or at least one coronary secondary diagnosis. We do not
report the estimates concerning the coefficients of the cross effects of gender and age : they are all
significant in equation (3) and show that the length of stay increases with age and is higher for
women at all ages. These effects all increase between 1994 and 1997, indicating that the decrease
in the length of stays, revealed by the change in the constant, is not homogenous for all patients.
Being assigned to an innovative hospital has a significant influence on the length of the stay
(Table 2). This influence is positive in 1994, but becomes negative in 1997. This result, which may
seem surprising, is understandable in the French context of the global budget system. During the
period 1994-1997 covered by our study, budgets increased rather slowly and had no direct link to
the actual production of hospitals. In that context, one way to extend the use of innovative (and
costly) procedures was for an establishment to reduce the length of stays as much as possible. In
any case, we observe that this behavior concerns all patients treated in an innovative hospital : for
a given stay, the performance of an angioplasty does not significantly influence the length of the
stay.
Another noteworthy result is the positive and significant influence of secondary diagnoses on the
length of the stay. By contrast, secondary diagnoses appear to have no significant direct influence
on the cost of the stay (see the two last columns of table 2). However, the length of the stay has
a significant influence on costs, with a coefficient12 of about 0.9. Therefore we can deduce that the
secundary diagnoses have an indirect influence on costs, through the length of stays.
Costs are significantly higher in innovative hospitals. In 1994, they are 27.8 % higher. The esti-
mated difference drops to 17.4 % in 1997. We find also that performing an angioplasty significantly
increases the cost of a stay : + 30.1 % in 1994. The corresponding coefficient is 38.9 % in 199713.
This increase may be linked to changes in the technology of angioplasty (introduction of stents)
and changes in supply prices.
To sum up, age and secundary diagnoses have a positive effect on the length of stay, which, in
12which does not change much between 1994 and 1997.
13This last coefficient appears to be not significant. However, we lost much of the variability of proc since we had
to use its predicted values to deal with the outcome of the Hausman test.
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turn, influences positively the cost of a stay. Costs are significantly higher in innovative hospitals
and when an angioplasty has been performed. Our descriptive analysis has shown that the patients’
state is worsening and that the use of innovative procedures is increasing rapidly, as well as the
proportion of innovative hospitals. Therefore, the cost of the stay is likely to be subject to strong
positive shocks. Our purpose is to study, within this context, the effect of the cost-containment
induced by the global budget constraint on the distributions of the cost and of the length of stay.
4.2 First decomposition of overall changes between 1994 and 1997
We first consider decompositions on means of the overall changes between 1994 and 1997, in the
spirit of the Oaxaca (1973) decomposition. For the sake of simplicity, we refer to the notation of a
linear model (such as the length of stay and cost equations (3) and (4)). One has :
Yi0 = Xi0β0 + ui0 and Yj1 = Xj1β1 + uj1,
where i and j are relative to patients observed, respectively, in years 0 and 1. In general, there
is no reason for the same patient to be observed in the two years. Xi0 and Xj1 are horizontal
vectors of the observations of explanatory variables for patients i and j, respectively. Denoting by
Y.0, Y.1,X.0,X.1 the sample means of the corresponding variables, and by
∧
β0 and
∧
β1 the estimated
coefficients, we can compute the following decomposition :
Y.1 − Y.0 = X.0 (
∧
β1 −
∧
β0) + (X.1 −X.0)
∧
β1 (15)
The first part of the right-hand side is the average change in Y due to shifts in the coefficients β.
The second part is the change in Y due to the average shift in patients’ observable characteristics
X.
This decomposition takes the year 0 as the reference for the variables X. Choosing the year 1
as the reference for X leads to another decomposition : Y.1 − Y.0 = X.1(
∧
β1 −
∧
β0) + (X.1 −X.0)
∧
β0.
The result of this last computation can be different but should be close to the result of (15).
We use the estimates of equations (1) to (4) to compute the decompositions defined on means
by (15). These are reported in table 3.
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They show that the rise in the average probability of being assigned to an innovative hospital (+
6.8 %) is due to shifts in coefficients (+ 2.8 %) and to changes in patient characteristics (+ 4.0 %).
By constrast, the dramatic increase (+ 32 %) in the use of angioplasty within innovative hospitals
is entirely due to changes in practices.
Changes in behavior induce a very sharp decrease in the length of stays (- 31.2 %), which is
only slightly compensated by shifts in the explanatory variables (+ 6.55 %). The fact that changes
in the explanatory variables tend to lengthen stays is mainly due to the secondary diagnoses : they
have a positive influence on the length of stays and their frequency is rising between 1994 and 1997.
However, the overall change in the length of the stays is strongly negative (-24.7 %) since it is
widely dominated by the impact of changes in behaviors, which tend to shorten stays.
Finally, we notice that the average increase in cost per stay is rather small : + 5 % only, for
nominal cost. This illustrates the strength of the global budget constraint during this period. How
did hospitals deal with this financial constraint ? The decomposition of table 3 shows that changes
due to shifts in explanatory variables are positive (+ 7.9 %) whereas changes dues to shifts in
coefficients are negative (- 2.9 %). Apparently, hospitals tried to compensate for the extra costs
arising from the increasing use of angioplasty by changing their behavior.
However, the interpretation of such a decomposition calls for a more thorough analysis. Firstly,
changes in the explanatory variables of costs follow very different patterns between 1994 and 1997 :
the length of stays decreases sharply ; the probability of being assigned to an innovative hospital
rises ; the probability of being treated by an angioplasty rises. Secondly, the empirical exercice that
we carry out in the decomposition of table 3 is rather limited. Indeed, the expression (15) is limited
to one equation and assumes that there is a radical separation between changes in coefficients and
changes in variables. In a more rigorous approach, one has to take into account the full information
arising from the structural four-equation model. In this case, changes in the coefficients of, say,
(1) and (2) induce changes in endogenous variables such as the length of stay in (4). This ”full-
information” approach is applied in the next subsection.
Notice, before, that we could extend the principle of decompositions on means to a similar
analysis of the changes in distributions. Denote d(Yi0) and d(Yj1) the distributions of variables Yi0
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and Yj1, i = 1, ..., I, j = 1, ..., J. One has, along the same reasoning as (15) :
d(Yj1)− d(Yi0) = d(Xi0
∧
β1 +
∧
ui0)− d(Xi0
∧
β0 +
∧
ui0)| {z }+ d(Xj1∧β1 + ∧uj1)− d(Xi0∧β1 + ∧ui0)| {z } (16)
The resulting decompositions of the changes in distributions are illustrated by graphs 11 and
12 in the annex. However, it is more relevant to use a full information approach in order to identify
the impact of technological progress diffusion on the distributions.
4.3 Analysing changes in the distributions of treatment costs and length
of stays : the impact of technological progress diffusion
We now consider the approach defined in subsection 3.2. From the structural model defined by
(1) to (4), we can express the distributions of Log(LOS) and Log(C) at time τ as vector functions
of observable and unobservable patient’s characteristics and of the parameters at date τ . The
overall distribution Λ0 of the logarithms of the length of stays at time 0 is defined by (5) : Λ0 =
Λ {x0i0, εi0 ; (B0,D0, d0, a0, p0, c0)} . To evaluate the impact of technological progress we want to
measure two effects : firstly, the effect of the growing adoption of new techniques by hospitals ;
secondly, the effects of the increasing use of angioplasty within hospital.
- The between hospital diffusion is linked to the change from B0 to B1 in the coefficients
of (1). The results of our estimates revealed that this change if far from negligible. With given
characteristics, a patient has a higher probability of being assigned to an innovative hospital in 1997
than in 1994. Using the estimates, we can simulate the counterfactual distribution (8) Λ0.1(B) =
Λ {x0i0, εi0 ; (B1,D0, d0, a0, p0, c0)} and evaluate the effect of the between hospital diffusion on the
distribution of the length of stay by (7) : dΛ
0.1(B) = Λ0.1(B) − Λ0.
- The within hospital diffusion is linked to the change from D0 to D1 in the coefficients of
(2). We have seen that the growth in the use of angioplasty is very rapid and entirely due to a
change in the coefficients of (2) : with given characteristics, the probability of being treated by an
angioplasty is much higher in 1997 than in 1994. To evaluate the effect of the between and within
hospital diffusion on the distribution of the length of the stay, we use the estimates to simulate the
counterfactual distribution : Λ0.1(B.D) = Λ {x0i0, εi0 ; (B1,D1, d0, a0, p0, c0)}. The difference in the
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distributions is defined by (9) : dΛ
0.1(B.D) = Λ0.1(B.D) − Λ0.
The same reasoning applies to the analysis of the impact of between and within diffusion on the
distribution Γ of the logarithms of the costs of the stays, with the distribution in year 0 defined by
(6) : Γ0 = Γ {x0i0, i0 ; (B0,D0, d0, a0, p0, c0, δ0, θ0, α0, π0, γ0)}.
Graph 3 displays the distributions Λ0, Λ0.1(B) and Λ0.1(B.D). Graphs 3a and 3b display, with
the same scale, the differences dΛ
0.1(B) and dΛ0.1(B.D) , which make it possible to evaluate the effects
of the between and within diffusion.
These effects appear to be rather small14 . As concerns the within effect, this is not surprising :
the performance of an angioplasty has no significant influence on the length of the stay (table
2). As for the between diffusion effect, it is rather surprising not to find a more sizeable effect,
since the estimates revealed that being assigned to an innovative hospital has a significant positive
influence on the length of the stay in 1994 : it is this coefficient which is used here to simulate the
counterfactual distribution Λ0.1(B).
Turning now to the cost of the stays, graph 4 displays the distributions Γ0, Γ0.1(B) and Γ0.1(B.D).
Graphs 4a and 4b display, with the same scale, the differences dΓ
0.1(B) and dΓ0.1(B.D) , computed in
order to evaluate the effects of the between and within diffusion.
Both effects appear to be quite sizeable. They induce an average rise in costs : the frequency of
low-cost stay decreases whereas the frequency of expensive stays increases. The cumulated effects
of between and within diffusion (graph 4b) is much larger than the between effect alone (graph
4a). It is worthwhile to notice that the positive shock on costs is limited to a specific place in the
distribution15.
4.4 Changes in the distributions : the impact of the worsening of pa-
tients’ epidemiological state
The descriptive analysis of our data revealed that AMI patients are aging and that their epide-
miological state is worsening : the number of secondary diagnoses increases rapidly. In addition, the
estimates show that age and indicators of coronary and non coronary secondary diagnoses influence
14We use the same scale for these graphs and the graphs relative to the changes in patient characteristics, which
induces a rather large scale for the impacts evaluated here.
15 Such result gives empirical support to a regulation which would propose a lump-sum prospective payment for a
stay associated with the performance of an angioplasty.
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significantly the length of the stay (table 2).
To decompose the population effect into what is due to the observable characteristics and
what can be attributable to unobserved heterogeneity, we simulate a change in the distribu-
tion of unobservable characteristics through the rank-preserving transformation defined by (10) :
εi,0.1 = εi0
σ1
σ0
, and compute (11) : dΛ0.1(ε) = Λ0.1(ε) − Λ0, with Λ0.1(ε) defined by (12) : Λ0.1(ε) =
Λ {x0i0, εi,0.1 ; (B0,D0, d0, a0, p0, c0)} .
To evaluate the additional effect of changes in observable characteristics, one has to consider
other individuals observed in year 1 : dΛ0.1(x.ε) = Λ0.1(x.ε)−Λ0, with Λ0.1(x.ε) defined by : Λ0.1(x.ε) =
Λ
©
x0j1, εj,1 ; (B0,D0, d0, a0, p0, c0)
ª
.
The same reasoning is applied to evaluate the effects on the cost distribution of changes in
patients’ observable characteristics and unobserved heterogeneity.
Graphs 5 displays the distributions of Λ0, Λ0.1(ε)and Λ0.1(x.ε). Graphs 5a and 5b give, res-
pectively, the differences : dΛ0.1(ε) and dΛ0.1(x.ε). Graph 5a shows that changes in unobservable
heterogeneity result in more variability of the length of the stay. The change arising from shifts in
patients’ observable characteristics is quite sizeable (graph 5b). The worsening of the epidemiological
state of patients in 1997, together with their aging, tend to lengthen hospital stays.
Graphs 6 displays the distributions of Γ0, Γ0.1(ε) and Γ0.1(x.ε). Graphs 6a and 6b give, respecti-
vely, the differences : dΓ0.1(ε) and dΓ0.1(x.ε). The change arising from shifts in patients’ observable
characteristics is quite sizeable and results in an increase in the average cost per stay (graph 6b).
Given the fact that age and secondary diagnoses are not significant in the cost equation, this effect
results from an indirect influence of these variables through the length of stay, which is an expla-
natory variable of the cost (we have seen the sharp increase in the length of stays due to changes
in patients’ characteristics).
4.5 Changes in the distributions : the influence of shifts in LOS behavior
Our results show that between 1994 and 1997 hospital costs were subject to two positive shocks :
diffusion of technological progress and worsening of patients’ epidemiological state. Cumulating the
effects of these two factors leads to a sizeable shock on cost distribution, which is much larger than
the total change in cost distribution observed between 1994 and 1997 (compare graphs 3b and 5b
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to graph 1a). In fact, the costs in the French public hospitals of our sample were limited by the
global budget, which increased very slowly. In other words, French hospitals made it possible to
provide a rapid diffusion of costly innovative procedures, despite two unfavorable conditions : cost
containment and the worsening state of patients.
How did hospitals manage to increase their use of innovative procedures, despite the financial
constraint induced by the global budget ? They reduced sharply their length of stay. Indeed, the
most dramatic change that occured during the period was a change in the coefficients of the LOS
equation between 1994 and 1997, which induced a tendency to shorten stays. More precisely, the
results of the estimates (see subsection 4.1) show that there is a substantial reduction in the constant
of equation (3) between 1994 and 1997 : -22.5 %. In addition, being assigned to an innovative hospital
has a significant positive influence on the length of the stay in 1994, which becomes negative in
1997. The impact of this behavior changes on the distribution of length of stays is represented at
the bottom of graph 7 (or in the appendix, graph 11a).
Graph 7 displays a synthesis of the changes in the LOS distribution and of the main shocks
which affected this distribution between 1994 and 1997. We observe that the overall change is a
tendency to shorten stays (graph 7a). The decomposition of this change into its main components
show that (i) the impact of technological progress diffusion (graph 7b) is positive (lengthening of
stays), but very small ; (ii) the impact of changes in patients characteristics is sizeable and tend to
lengthen stays (graph 7c) ; taken together, these two effects are smaller than the very large impact
of behavior change, represented in graph 7d. This last and negative effect widely dominate the
impact of the worsening of the patients’ state : on the whole, we observe a tendency to shorten
stays.
This change in hospital behavior as regards length of stays induced cost savings. To evaluate
these savings, we simulated the cost distribution in the year 1994, with the patients observed in 1994,
but with the behavior estimated in 1997 as regards exclusively the length of stays. In other words, we
simulated the following distribution16 : Γ0.1(LOS) = Γ {x0i0, i0 ; (B0,D0, d1, a1, p1, c1, δ0, θ0, α0, π0, γ0)} .
The difference : dΓ
0.1(LOS) = Γ0.1(LOS) − Γ0 gives the savings in costs due to the changes in the
16Notice that d, a, p and c are the coefficients of the LOS equation.
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coefficients of the length of the stay function. Graph 8 displays the distribution of Γ0 and Γ0.1(LOS).
Graph 8a gives the difference : dΓ
0.1(LOS) . These graphs reveal the magnitude of the cost savings
induced by the change in LOS behavior.
Graph 9 displays a synthesis of the changes in the cost distribution and of the main shocks
which affected this distribution between 1994 and 1997. The overall change is a rather limited rise
in costs, linked to the small increase in global budgets (graph 9a). The decomposition of this change
into its main components show that (i) the impact of technological progress diffusion (graph 9b)
is positive and sizeable ; (ii) the impact of changes in patients characteristics is positive and even
larger (graph 9c) ; the saving effect of shifts in the coefficients of the length of stay equation (graph
9d) is larger and widely compensates the effects on costs of the diffusion of innovative procedures
(9b). On the whole, this last and negative effect partly dominates the cumulated impact of the
technological progress diffusion (graph 9b) and of the worsening of the patients’ state (graph 9c) :
the overall rise in costs is limited.
How did the hospitals succeed in such a shortening of the length of stays ? Graph 10 allows
us to examine more thoroughly the changes that occured on the LOS distribution. We have seen
(graph 7) that this distribution was subject to two main shocks : the effect of the worsening state
of patients and the effect of changes in behavior. The curves corresponding to these two effects
are superimposed on graph 10, together with a vertical line which represents the first quartile
of the length of stays in the year 1994. We notice that the effect of the shortening of the stays
linked to the change in behavior takes place around the first quartile, i.e. more on the left of the
distribution in comparison to the lengthening of stays due to changes in patient characteristics. This
result suggests that hospitals concentrate their effort of reduction (and maybe, take some risks) on
patients of the bottom of the distribution of the length of stay, which can be interpreted as patients
without complications.
5 Conclusion
To sum up, between 1994 and 1997, hospitals faced two main causes of rises in costs : on the one
hand, diffusion of technological progress, with increasing use of costly innovative procedures such as
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angioplasty ; on the other hand, patients’ epidemiological state worsened, since they became older
and had more secondary diagnoses. These two factors induced shocks in the cost distributions.
During the same period, French public hospitals were financed by a global budget, and their
budgets increased very slowly. Hence, growth in overall average costs was limited by the rather
slow rate of growth in global budgets. However, international comparisons show that diffusion of
technological progress for AMI treatment is similar in France and in comparable countries (TECH
(2001)). How did French hospitals deal with their financial constraints ? Our results show that they
sharply reduced the length of stays for patients at the bottom of the distribution. This reduction
in the length of stays appears to have been a condition for the diffusion of angioplasty. Obviously,
such a condition cannot be sustained in the long run without jeopardizing quality of care.
Regarding methodology, our study refers to Juhn, Murphy and Pierce (1993), DiNardo, Fortin
and Lemieux (1996) and Bourguignon, Ferreira and Leite (2002)), all of whom focus on income
distribution. In this paper, most observed changes are in means, not in spread. The main interest
of our decompositions is that they reveal that the changes in means do not lie at the same place in
the distribution, depending on the effect considered.
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Table 1: Basic features of the data 
 
 1994 1997 
Number of stays 2,269 3,412 
Gender (proportion of female) 29.7 31.2 
Average age (year) 67 67 
Number of secondary diagnoses (percentage):   
 None 26.6 10.6 
 1-3 57.7 51.8 
 Over 3 15.7 37.6 
At least one non coronary secondary diagnosis 
(percentage) 45.0 71.1 
At least one coronary secondary diagnosis 
(percentage) 59.1 70.7 
Patient’s 
characteristics 
Angioplasty (percentage) 
4.8 15.6 
Average LOS (days) 11.6 9.7 
(Standard deviation) (7.1) (7.0) 
                        Stay without angioplasty 11.6 9.9 
(Standard deviation) (7.1) (7.0) 
Stay with angioplasty  11.8 8.5 
Length of stay  
(Standard deviation)  (6.1) (6.8) 
Average cost (euros) 4,361.7 4,611.2 
(Standard deviation)  (2,980.0) (3,088.9) 
                        Stay without angioplasty 4,252.7 4,334.5 
(Standard deviation) (2,947.9) (2,914.5) 
Stay with angioplasty  6,542.7 6,109.3 
Cost 
(Standard deviation)  (2,784.8) (3,546.9) 
PMSI database: 2,269 and 3,412 AMI stays in 1994 and 1997 
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Figure 1: Frequency of coronary secondary diagnoses 
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PMSI database: 2,269 and 3,412 AMI stays in 1994 and 1997 
TC: arrhythmia  
MH: hypertension 
IC: heart failure   
 
 
 
 
Figure 2: Frequency of other coronary secondary diagnoses 
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PMSI database: 2,269 and 3,412 AMI stays in 1994 and 1997 
CER: cerebro-vascular disease   
AR: peripheral arterial disease 
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Figure 3: Patients’ characteristic. Age and gender  
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Figure 4: PTCA diffusion (Between and Within) 
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PMSI database: 2,269 and 3,412 AMI stays in 1994 and 1997 
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Graph 1: Distribution of the logarithm of the length of stay in 1994 (Λ0) and 1997 (Λ1) 
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PMSI database: 2,269 and 3,412 AMI stays in 1994 and 1997 
 
 
Graph 1a: Change in the distribution between 1994 and 1997 (Λ0 - Λ1) 
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Graph 2: Distribution of the logarithm of the cost of stay in 1994 (Γ0) and 1997 (Γ1) 
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Graph 2a: Change in the distribution between 1994 and 1997 (Γ1 - Γ0) 
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Table 2: Estimated coefficients for Equations (3) Length of stay and (4) Cost 
 
 Log(LOS) Log(C) 
 94 97 94 97 
Non coronary 
secondary diagnosis 
0.314** 
(0.029) 
0.074** 
(0.029) 
0.006 
(0.050) 
0.049 
(0.034) 
Coronary secondary 
diagnosis 
0.163** 
(0.031) 
0.332** 
(0.031) 
0.052 
(0.040) 
0.044 
(0.053) 
Log(LOS) 
 
Hausman Test for  
H0 : exogeneity 
- 
 
- 
- 
 
- 
0.899** 
(0.136) 
H0 rejected  
(0.036) 
0.849** 
(0.096) 
H0 rejected  
(0.001) 
Innovative Hospital 
 
Hausman Test for  
H0 : exogeneity 
0.129** 
(0.031) 
H0  non rejected 
(0.050) 
-0.139** 
(0.032) 
H0  non rejected 
(0.848) 
0.278** 
(0.030) 
H0  non rejected 
(0.437) 
0.174** 
(0.024) 
H0  non rejected 
(0.609) 
Angioplasty 
 
Hausman Test for  
H0 : exogeneity 
-0.028 
(0.061) 
H0  non rejected 
(0.269) 
-0.008 
(0.047) 
H0  non rejected 
(0.163) 
0.301** 
(0.068) 
H0  non rejected 
(0.103) 
0.389 
(0.429)1 
H0 rejected 
 (0.022) 
**: The estimated coefficient is significant at 1 % level. 
Models also included patient characteristics. When the Hausman’s test leads to rejection of the null 
hypothesis, the corresponding variable is instrumented in the regression. In the present version of the 
paper we only computed the second step standard errors in those cases.  
1 Consistently estimated standard error by bootstrap (1000 replications) 
 
 
Table 3: Overall changes between 1994 and 1997: first decomposition on means 
 
Equation   
Total changes  
1994 – 1997 (%)
 
(1) 
Changes due to 
shifts in 
coefficients 
(2) 
Changes due to 
shifts in 
explanatory 
variables 
(3) 
(1) 
Assignment to 
an innovative 
hospital 
+ 6.8 + 2.8 (+ 6.5) 
+ 4.0 
(+ 0.3) 
(2) Treatment by an angioplasty  + 32.0 
+ 32.0 
(+ 27.0) 
0.0 
(+ 5.0) 
(3) Length of stay - 24.7 - 31.2 (- 35.36) 
+ 6.55 
(+ 10.68) 
(4) Cost of stay + 5.0 - 2.9 (- 10.1) 
+ 7.9 
(+ 15.1) 
The decompositions given here take the year 1994 as a reference for the explanatory variables. In parentheses 
are given the decompositions resulting from the other possible computation, which takes the year 1997 as a 
reference for the explanatory variables. 
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 Graph 3: Distribution of ln(LOS) in 1994 and counterfactual distributions of ln(LOS) to 
evaluate the impact of technological progress diffusion 
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PMSI database: 2,269 and 3,412 AMI stays in 1994 and 1997 
ln(LOS), 94: distribution of ln(LOS) observed in 1994 
ln(LOS), 94. 97(B): counterfactual distribution of ln(LOS) in 1994 due to the rise in the number of innovative 
hospitals in 1997 
ln(LOS), 94. 97(B,D): counterfactual distribution of ln(LOS) in 1994 due to the rise in the number of innovative 
hospitals in 1997 and to the increase in the probability of angioplasty 
 
 
 
Graph 3a: Effect of between hospital diffusion on 
the distribution of ln(LOS) 
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Graph 3b: Cumulated effect of between and within 
diffusion of the distribution of ln(LOS) 
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Graph 4: Distribution of ln(cost) in 1994 and counterfactual distributions of ln(cost) to 
evaluate the impact of technological progress diffusion 
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PMSI database: 2,269 and 3,412 AMI stays in 1994 and 1997 
ln(cost), 94: distribution of ln(cost) observed in 1994 
ln(cost), 94. 97(B): counterfactual distribution of the ln(cost) in 1994 due to the rise in the number of innovative 
hospitals in 1997 
ln(cost), 94. 97(B,D): counterfactual distribution of the ln(cost) in 1994 due to the rise in the number of 
innovative hospitals in 1997 and to the increase in the probability of angioplasty 
 
 
Graph 4a: Effect of between hospital diffusion 
on the distribution of ln(cost) 
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Graph 4b: Cumulated effect of between and within 
diffusion of the distribution of ln(cost) 
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Graph 5: Distribution of ln(LOS) in 1994 and counterfactual distributions of ln(LOS) to 
evaluate the impact of changes in observable and unobservable patients’ 
characteristics  
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PMSI database: 2,269 and 3,412 AMI stays in 1994 and 1997 
 
 
 
Graph 5a: Effect of changes in unobservable 
heterogeneity on the distribution of 
ln(LOS) 
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Graph 5b: Effect of changes in unobservable 
heterogeneity and observable patients’ 
characteristics on the distribution of 
ln(LOS) 
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Graph 6: Distribution of ln(cost) in 1994 and counterfactual distributions of ln(cost) to 
evaluate the impact of observable and unobservable patients’ characteristics 
change 
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PMSI database: 2,269 and 3,412 AMI stays in 1994 and 1997 
 
 
 
 
Graph 6a: Effect of changes in unobservable 
heterogeneity on the distribution of ln(cost)
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Graph 6b: Effect of changes in unobservable 
heterogeneity and observable patients’ 
characteristics on the distribution of ln(cost) 
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Graphs 7 : LOS distribution : overall change and main shocks between 1994 
and 1997. 
Graph 7a: Overall change in the distribution between 1994 and 1997 (Λ0 - Λ1) 
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Graph 7b: Cumulated effect of between and within diffusion of the distribution of ln(LOS) 
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Graph 7c: Effect of changes in unobservable heterogeneity and observable patients’ characteristics on the distribution of ln(LOS) 
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Graph 7d: Change in the distribution due to shifts in the coefficients  d(X i0β1+ui0) - d(X i0β0+ui0) 
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Graph 8: Distribution of ln(cost) in 1994 and counterfactual distribution of ln(cost) to evaluate 
the impact of changes in the LOS behavior between 1994 and 1997 
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PMSI database: 2,269 and 3,412 AMI stays in 1994 and 1997 
ln(cost), 94: distribution of ln(cost) observed in 1994 
pred. ln(cost)94.97(LOS): counterfactual distribution of ln(cost) with patients observed in 1994 and 
coefficients of 1997 for the prediction of LOS exclusively 
 
 
 
Graph 8a: Savings in cost due to changes in the LOS behavior between 1994 and 1997 
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Graphs 9 : Costs distribution : overall change and main shocks between 1994 
and 1997. 
Graph 9a: Overall change in the distribution between 1994 and 1997 (Γ1 - Γ0) 
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Graph 9b: Cumulated effect of between and within diffusion of the distribution of ln(cost) 
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Graph 9c: Effect of changes in unobservable heterogeneity and observable patients’ characteristics on the distribution of ln(cost) 
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Graph 9d: Savings in cost due to changes in the LOS behavior between 1994 and 1997 
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Graph 10: LOS distribution : comparison of effect of changes in behavior 
and effect of changes in patients' characteristics.  
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Annex 
 
Graph 11: Decomposition of change 1994-1997 in the distribution of the logarithm of the 
length of stay (called ln(LOS)) 
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PMSI database: 2,269 and 3,412 AMI stays in 1994 and 1997 
ln(LOS), 94: d(X i0β0+ui0), observations 94, coefficients 94 
ln(LOS), 94: d(X i0β1+ui0), observations 94, coefficients 97 
ln(LOS), 94: d(X j1β1+u j1), observations 97, coefficients 97 
 
 
 
 
 
Graph 11a: Change in the distribution due to shifts 
in the coefficients 
 d(X i0β1+ui0) - d(X i0β0+ui0) 
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Graph 11b: Change in the distribution due to shifts in the 
explanatory variables and patients’ 
unobservable characteristics 
d(X j1β1+u j1) - d(X i0β1+ui0) 
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Graph 12: Decomposition of change 1994-1997 in the distribution of the logarithm of the cost 
of stay (called ln(cost)) 
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PMSI database: 2,269 and 3,412 AMI stays in 1994 and 1997 
ln(cost), 94: d(X i0β0+ui0), observations 94, coefficients 94 
ln(cost), 94: d(X i0β1+ui0), observations 94, coefficients 97 
ln(cost), 94: d(X j1β1+u j1), observations 97, coefficients 97 
 
Graph 12a: Change in the distribution due to shifts 
in the coefficients 
d(X i0β1+ui0) - d(X i0β0+ui0) 
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Graph 12b: Change in the distribution due to shifts in 
explanatory variables and patients’ 
unobservable characteristics 
d(X j1β1+u j1) - d(X i0β1+ui0) 
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